151 related articles for article (PubMed ID: 27142111)
1. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
Sasaki Y; Yoshino N; Sato S; Muraki Y
J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
[TBL] [Abstract][Full Text] [Related]
2. Treatment of influenza virus with beta-propiolactone alters viral membrane fusion.
Bonnafous P; Nicolaï MC; Taveau JC; Chevalier M; Barrière F; Medina J; Le Bihan O; Adam O; Ronzon F; Lambert O
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):355-63. PubMed ID: 24140008
[TBL] [Abstract][Full Text] [Related]
3. Effect of the β-propiolactone treatment on the adsorption and fusion of influenza A/Brisbane/59/2007 and A/New Caledonia/20/1999 virus H1N1 on a dimyristoylphosphatidylcholine/ganglioside GM3 mixed phospholipids monolayer at the air-water interface.
Desbat B; Lancelot E; Krell T; Nicolaï MC; Vogel F; Chevalier M; Ronzon F
Langmuir; 2011 Nov; 27(22):13675-83. PubMed ID: 21981550
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation.
Pawar SD; Murtadak VB; Kale SD; Shinde PV; Parkhi SS
J Virol Methods; 2015 Sep; 222():28-33. PubMed ID: 25997377
[TBL] [Abstract][Full Text] [Related]
5. Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
Herrera-Rodriguez J; Signorazzi A; Holtrop M; de Vries-Idema J; Huckriede A
Vaccine; 2019 Mar; 37(12):1630-1637. PubMed ID: 30765167
[TBL] [Abstract][Full Text] [Related]
6. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.
Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783
[TBL] [Abstract][Full Text] [Related]
7. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training.
Pilchová V; Prajeeth CK; Jendrny P; Twele F; Meller S; Pink I; Fathi A; Addo MM; Volk HA; Osterhaus A; von Köckritz-Blickwede M; Schulz C
J Virol Methods; 2023 Jul; 317():114733. PubMed ID: 37068591
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential.
Gupta D; Parthasarathy H; Sah V; Tandel D; Vedagiri D; Reddy S; Harshan KH
Virus Res; 2021 Nov; 305():198555. PubMed ID: 34487766
[TBL] [Abstract][Full Text] [Related]
9. The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors.
Refaie FM; Esmat AY; Mohamed AF; Mohamed WA
Egypt J Immunol; 2004; 11(2):9-20. PubMed ID: 16734113
[TBL] [Abstract][Full Text] [Related]
10. Intravirion cohesion of matrix protein M1 with ribonucleocapsid is a prerequisite of influenza virus infectivity.
Zhirnov OP; Manykin AA; Rossman JS; Klenk HD
Virology; 2016 May; 492():187-96. PubMed ID: 26954078
[TBL] [Abstract][Full Text] [Related]
11. [pH-dependent rearrangements in the influenza A virus].
Zhirnov OP; Manykin AA
Vopr Virusol; 2014; 59(3):41-6. PubMed ID: 25335418
[TBL] [Abstract][Full Text] [Related]
12. Complement-Independent Modulation of Influenza A Virus Infection by Factor H.
Murugaiah V; Varghese PM; Saleh SM; Tsolaki AG; Alrokayan SH; Khan HA; Collison KS; Sim RB; Nal B; Al-Mohanna FA; Kishore U
Front Immunol; 2020; 11():355. PubMed ID: 32269562
[TBL] [Abstract][Full Text] [Related]
13. Relationship between hemagglutinin stability and influenza virus persistence after exposure to low pH or supraphysiological heating.
Yang G; Ojha CR; Russell CJ
PLoS Pathog; 2021 Sep; 17(9):e1009910. PubMed ID: 34478484
[TBL] [Abstract][Full Text] [Related]
14. The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus.
Wendel I; Rubbenstroth D; Doedt J; Kochs G; Wilhelm J; Staeheli P; Klenk HD; Matrosovich M
J Virol; 2015 Apr; 89(8):4170-9. PubMed ID: 25631088
[TBL] [Abstract][Full Text] [Related]
15. The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.
Anderson MC; Baer H; Frazier DJ; Quinnan GV
J Allergy Clin Immunol; 1987 Dec; 80(6):861-8. PubMed ID: 3693763
[TBL] [Abstract][Full Text] [Related]
16. Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.
Kamaraj G; Lakshmi Narasu M; Srinivasan VA
Res Vet Sci; 2008 Dec; 85(3):589-94. PubMed ID: 18262212
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates.
Scheidler A; Rokos K; Reuter T; Ebermann R; Pauli G
Biologicals; 1998 Jun; 26(2):135-44. PubMed ID: 9811521
[TBL] [Abstract][Full Text] [Related]
18. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
Deyde VM; Xu X; Bright RA; Shaw M; Smith CB; Zhang Y; Shu Y; Gubareva LV; Cox NJ; Klimov AI
J Infect Dis; 2007 Jul; 196(2):249-57. PubMed ID: 17570112
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]